Release Date: 26/02/09 13:05 Summary: Amended Full Year Results Announcement Price Sensitive: No Download Document 50.94KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%